Recent News

• 04.23.2025 - Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease
• 04.23.2025 - Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease
• 04.08.2025 - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
• 04.08.2025 - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
• 03.31.2025 - 2024 BIONANO FOURTH QUARTER FINANCIAL RESULTS CALL
• 03.31.2025 - 2024 BIONANO FOURTH QUARTER FINANCIAL RESULTS CALL
• 03.31.2025 - Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
• 03.31.2025 - Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
• 03.24.2025 - Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect
• 03.24.2025 - Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Recent Filings

• 04.18.2025 - PRE 14A Other preliminary proxy statements
• 04.02.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 04.02.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities